BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38308693)

  • 1. Cryptic exon inclusion is a molecular signature of LATE-NC in aging brains.
    Chung M; Carter EK; Veire AM; Dammer EB; Chang J; Duong DM; Raj N; Bassell GJ; Glass JD; Gendron TF; Nelson PT; Levey AI; Seyfried NT; McEachin ZT
    Acta Neuropathol; 2024 Feb; 147(1):29. PubMed ID: 38308693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of TDP-43 splicing repression occurs early in the aging population and is associated with Alzheimer's disease neuropathologic changes and cognitive decline.
    Chang K; Ling JP; Redding-Ochoa J; An Y; Li L; Dean SA; Blanchard TG; Pylyukh T; Barrett A; Irwin KE; Moghekar A; Resnick SM; Wong PC; Troncoso JC
    Acta Neuropathol; 2023 Dec; 147(1):4. PubMed ID: 38133681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive symptoms progress with limbic-predominant age-related TDP-43 encephalopathy stage and co-occurrence with Alzheimer disease.
    Hiya S; Maldonado-Díaz C; Walker JM; Richardson TE
    J Neuropathol Exp Neurol; 2023 Dec; 83(1):2-10. PubMed ID: 37966908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptomatic Profile and Cognitive Performance in Autopsy-Confirmed Limbic-Predominant Age-Related TDP-43 Encephalopathy With Comorbid Alzheimer Disease.
    Gauthreaux K; Mock C; Teylan MA; Culhane JE; Chen YC; Chan KCG; Katsumata Y; Nelson PT; Kukull WA
    J Neuropathol Exp Neurol; 2022 Nov; 81(12):975-987. PubMed ID: 36264254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryptic exon incorporation occurs in Alzheimer's brain lacking TDP-43 inclusion but exhibiting nuclear clearance of TDP-43.
    Sun M; Bell W; LaClair KD; Ling JP; Han H; Kageyama Y; Pletnikova O; Troncoso JC; Wong PC; Chen LL
    Acta Neuropathol; 2017 Jun; 133(6):923-931. PubMed ID: 28332094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limbic-predominant age-related TDP-43 encephalopathy (LATE-NC): Co-pathologies and genetic risk factors provide clues about pathogenesis.
    Nelson PT; Fardo DW; Wu X; Aung KZ; Cykowski MD; Katsumata Y
    J Neuropathol Exp Neurol; 2024 May; 83(6):396-415. PubMed ID: 38613823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limbic-predominant age-related TDP-43 encephalopathy, ADNC pathology, and cognitive decline in aging.
    Kapasi A; Yu L; Boyle PA; Barnes LL; Bennett DA; Schneider JA
    Neurology; 2020 Oct; 95(14):e1951-e1962. PubMed ID: 32753441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing Limbic-Predominant Age-Related TDP-43 Encephalopathy Without Alzheimer's Disease and Lewy Body Dementia in the Oldest Old: A Case Series.
    Leiby AC; Scambray KA; Nguyen HL; Basith F; Fakhraee S; Melikyan ZA; Bukhari SA; Montine TJ; Corrada MM; Kawas CH; Sajjadi SA
    J Alzheimers Dis; 2023; 96(1):113-124. PubMed ID: 37742640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychiatric symptoms in limbic-predominant age-related TDP-43 encephalopathy and Alzheimer's disease.
    Liu KY; Reeves S; McAleese KE; Attems J; Francis P; Thomas A; Howard R
    Brain; 2020 Dec; 143(12):3842-3849. PubMed ID: 33188391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of Lewy bodies with limbic-predominant age-related TDP-43 encephalopathy neuropathologic changes and their role in cognition and Alzheimer's dementia in older persons.
    Agrawal S; Yu L; Nag S; Arfanakis K; Barnes LL; Bennett DA; Schneider JA
    Acta Neuropathol Commun; 2021 Sep; 9(1):156. PubMed ID: 34563269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limbic-predominant age-related TDP-43 encephalopathy neuropathologic change and microvascular pathologies in community-dwelling older persons.
    Agrawal S; Yu L; Kapasi A; James BD; Arfanakis K; Barnes LL; Bennett DA; Nag S; Schneider JA
    Brain Pathol; 2021 May; 31(3):e12939. PubMed ID: 33624322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Cognition and Dementia With Neuropathologic Changes of Alzheimer Disease and Other Conditions in the Oldest Old.
    Montine TJ; Corrada MM; Kawas C; Bukhari SA; White LR; Tian L; Cholerton B
    Neurology; 2022 Sep; 99(10):e1067-e1078. PubMed ID: 35705500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disentangling and quantifying the relative cognitive impact of concurrent mixed neurodegenerative pathologies.
    Maldonado-Díaz C; Hiya S; Yokoda RT; Farrell K; Marx GA; Kauffman J; Daoud EV; Gonzales MM; Parker AS; Canbeldek L; Kulumani Mahadevan LS; Crary JF; White CL; Walker JM; Richardson TE
    Acta Neuropathol; 2024 Mar; 147(1):58. PubMed ID: 38520489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact and Risk Factors of Limbic Predominant Age-Related TDP-43 Encephalopathy Neuropathologic Change in an Oldest-Old Cohort.
    Sajjadi SA; Bukhari S; Scambray KA; Yan R; Kawas C; Montine TJ; Corrada MM
    Neurology; 2023 Jan; 100(2):e203-e210. PubMed ID: 36302666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologic correlates of aging-related tau astrogliopathy: ARTAG is associated with LATE-NC and cerebrovascular pathologies, but not with ADNC.
    Katsumata Y; Wu X; Aung KZ; Gauthreaux K; Mock C; Forrest SL; Kovacs GG; Nelson PT
    Neurobiol Dis; 2024 Feb; 191():106412. PubMed ID: 38244935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limbic-Predominant Age-Related TDP-43 Encephalopathy: Medical and Pathologic Factors Associated With Comorbid Hippocampal Sclerosis.
    Gauthreaux KM; Teylan MA; Katsumata Y; Mock C; Culhane JE; Chen YC; Chan KCG; Fardo DW; Dugan AJ; Cykowski MD; Jicha GA; Kukull WA; Nelson PT
    Neurology; 2022 Apr; 98(14):e1422-e1433. PubMed ID: 35121671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance and resilience to Alzheimer's disease pathology are associated with reduced cortical pTau and absence of limbic-predominant age-related TDP-43 encephalopathy in a community-based cohort.
    Latimer CS; Burke BT; Liachko NF; Currey HN; Kilgore MD; Gibbons LE; Henriksen J; Darvas M; Domoto-Reilly K; Jayadev S; Grabowski TJ; Crane PK; Larson EB; Kraemer BC; Bird TD; Keene CD
    Acta Neuropathol Commun; 2019 Jun; 7(1):91. PubMed ID: 31174609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LATE-NC aggravates GVD-mediated necroptosis in Alzheimer's disease.
    Koper MJ; Tomé SO; Gawor K; Belet A; Van Schoor E; Schaeverbeke J; Vandenberghe R; Vandenbulcke M; Ghebremedhin E; Otto M; von Arnim CAF; Balusu S; Blaschko MB; De Strooper B; Thal DR
    Acta Neuropathol Commun; 2022 Sep; 10(1):128. PubMed ID: 36057624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct characteristics of limbic-predominant age-related TDP-43 encephalopathy in Lewy body disease.
    Uemura MT; Robinson JL; Cousins KAQ; Tropea TF; Kargilis DC; McBride JD; Suh E; Xie SX; Xu Y; Porta S; Uemura N; Van Deerlin VM; Wolk DA; Irwin DJ; Brunden KR; Lee VM; Lee EB; Trojanowski JQ
    Acta Neuropathol; 2022 Jan; 143(1):15-31. PubMed ID: 34854996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report.
    Nelson PT; Dickson DW; Trojanowski JQ; Jack CR; Boyle PA; Arfanakis K; Rademakers R; Alafuzoff I; Attems J; Brayne C; Coyle-Gilchrist ITS; Chui HC; Fardo DW; Flanagan ME; Halliday G; Hokkanen SRK; Hunter S; Jicha GA; Katsumata Y; Kawas CH; Keene CD; Kovacs GG; Kukull WA; Levey AI; Makkinejad N; Montine TJ; Murayama S; Murray ME; Nag S; Rissman RA; Seeley WW; Sperling RA; White CL; Yu L; Schneider JA
    Brain; 2019 Jun; 142(6):1503-1527. PubMed ID: 31039256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.